A Pilot Study of Gemcitabine, Abraxane, Metformin and a Standardized Dietary Supplement (DS) in Patients With Unresectable Pancreatic Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02336087

Title field or adapter rule

{'original_value': 'A Pilot Study of Gemcitabine, Abraxane, Metformin and a Standardized Dietary Supplement (DS) in Patients With Unresectable Pancreatic Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:23.145823+00:00

Published At

2026-10-19T00:00:00+00:00

Record Updated At

2026-10-19

Source Retrieved At

2026-10-31T22:17:52.415050+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreatic Adenocarcinoma", "Unresectable Pancreatic Carcinoma", "Stage III Pancreatic Cancer AJCC v6 and v7", "Stage IV Pancreatic Cancer AJCC v6 and v7"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-19", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT02336087"

protocolSection.identificationModule.officialTitle

"A Pilot Study of Gemcitabine, Abraxane, Metformin and a Standardized Dietary Supplement (DS) in Patients With Unresectable Pancreatic Cancer"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Unresectable Pancreatic Carcinoma (protocolSection.conditionsModule.conditions)
• Stage III Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage IV Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Treatment (gemcitabine, Abraxane, metformin, DS)'], 'description': 'Given IV', 'name': 'Gemcitabine Hydrochloride', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (gemcitabine, Abraxane, metformin, DS)'], 'description': 'Given IV', 'name': 'Paclitaxel Albumin-Stabilized Nanoparticle Formulation', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (gemcitabine, Abraxane, metformin, DS)'], 'description': 'Given PO', 'name': 'Metformin Hydrochloride', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (gemcitabine, Abraxane, metformin, DS)'], 'description': 'Given PO', 'name': 'Therapeutic Dietary Intervention', 'type': 'DIETARY_SUPPLEMENT'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (gemcitabine, Abraxane, metformin, DS)'], 'description': 'Correlative studies', 'name': 'Laboratory Biomarker Analysis', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (gemcitabine, Abraxane, metformin, DS)'], 'description': 'Ancillary studies', 'name': 'Quality-of-Life Assessment', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Gemcitabine Hydrochloride (protocolSection.armsInterventionsModule.interventions[].name)
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation (protocolSection.armsInterventionsModule.interventions[].name)
• Metformin Hydrochloride (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.